Henry Schein Elects Dr. E. Dianne Rekow To Board Of Directors

Dean of King's College London Dental Institute Brings In-Depth Expertise in the Fields of Digital Dentistry, Dental Materials and Products, and Dental Education

Jun 03, 2014, 16:05 ET from Henry Schein, Inc.

MELVILLE, N.Y., June 3, 2014 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today the election of Professor E. Dianne Rekow, D.D.S., Ph.D., to the Company's Board of Directors.  Dr. Rekow, Dean of King's College London Dental Institute and Professor of Orthodontics, brings to the Henry Schein Board extensive experience in innovative dental products, practices, and education, as well as keen insights into global trends influencing the evolution of the dental profession.

"In a global dental environment that is quickly evolving through the power of digital technology, we are very pleased to welcome Dr. Rekow to the Henry Schein Board of Directors," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Dr. Rekow is a recognized pioneer in the field of digital dentistry, an expert in the development and performance of dental materials and products, and a global thought leader in dental education.  We look forward to benefitting from her unique perspective and strategic insights, as Henry Schein continues to focus on providing digital dental solutions to our customers around the world."

Dr. Rekow has a long and distinguished career in dentistry, including a decade as a Professor of Orthodontics at New York University, as well as senior roles at multiple dental and scientific associations.  An internationally recognized authority on the performance of new materials and products for use in aesthetic and restorative dentistry, Dr. Rekow has been a leader in research on the use of bio-engineered tissue to facilitate bone replacement in individuals who have been disfigured by disease or developmental defects as well as research in elucidating damage initiation and propagation in brittle materials. Dr. Rekow also holds a number of patents in the dental field and is the author of, or contributor to, more than one hundred publications.

"It is a pleasure to join the Board of a company that is committed to technology leadership in all facets of its business," said Dr. Rekow.  "Not only has Henry Schein been a pioneer in meeting the needs of its dental, animal health and medical customers for decades, but through its continual reinvention of the organization, Henry Schein has also helped recreate and advance the markets that it serves.  I look forward to being part of such a future-focused company and to helping Henry Schein sustain the admirable leadership role it has forged."     

Prior to joining Kings College, Dr. Rekow was a Professor of Orthodontics at New York University (NYU) from 2002 to 2012, also serving as Senior Vice Provost of Engineering Technology at NYU from 2008 to 2012, and, as Provost of Polytechnic Institute of NYU from 2009 to 2012.  Dr. Rekow has served as President of the International Association for Dental Research (IADR) and the American Association of Dental Research (AADR), and since 2000 she has been an American Dental Association Consultant to the Council on Scientific Affairs.  In 2011, Dr. Rekow was elected to the Faculty of Dental Surgery of the Royal College of Surgeons of England.

About Henry Schein, Inc. Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners.  The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.  A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs nearly 17,000 Team Schein Members and serves more than 800,000 customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care.  Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items.  The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 27 countries.  The Company's sales reached a record $9.6 billion in 2013, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995.  For more information, visit the Henry Schein website at www.henryschein.com.

Photo - http://photos.prnewswire.com/prnh/20140603/93866 

SOURCE Henry Schein, Inc.